|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM353171956 |
003 |
DE-627 |
005 |
20231226055410.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202208820
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1177.xml
|
035 |
|
|
|a (DE-627)NLM353171956
|
035 |
|
|
|a (NLM)36810905
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Li, Xianlei
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Fluorescence-Amplified Origami Microneedle Device for Quantitatively Monitoring Blood Glucose
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 21.07.2023
|
500 |
|
|
|a Date Revised 21.07.2023
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2023 Wiley-VCH GmbH.
|
520 |
|
|
|a Exploration of clinically acceptable blood glucose monitors has been engaging in the past decades, yet the ability to quantitatively detect blood glucose in a painless, accurate, and highly sensitive manner remains limited. Herein, a fluorescence-amplified origami microneedle (FAOM) device is described that integrates tubular DNA-origami nanostructures and glucose oxidase molecules into its inner network to quantitatively monitor blood glucose. The skin-attached FAOM device can collect glucose molecules in situ and transfer the input into a proton signal after the oxidase's catalysis. The proton-driven mechanical reconfiguration of DNA-origami tubes separates fluorescent molecules and their quenchers, eventually amplifying the glucose-correlated fluorescence signal. The function equation established on clinical examinees suggests that FAOM can report blood glucose in a highly sensitive and quantitative manner. In clinical blind tests, the FAOM achieves well-matched accuracy (98.70 ± 4.77%) compared with a commercial blood biochemical analyzer, fully meeting the requirements of accurate blood glucose monitoring. The FAOM device can be inserted into skin tissue in a trivially painful manner and with minimal leakage of DNA origami, substantially improving the tolerance and compliance of the blood glucose test
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a DNA origami
|
650 |
|
4 |
|a blood glucose
|
650 |
|
4 |
|a fluorescence quantification
|
650 |
|
4 |
|a microneedle patches
|
650 |
|
4 |
|a proton-driven
|
650 |
|
7 |
|a Blood Glucose
|2 NLM
|
650 |
|
7 |
|a Protons
|2 NLM
|
650 |
|
7 |
|a DNA
|2 NLM
|
650 |
|
7 |
|a 9007-49-2
|2 NLM
|
650 |
|
7 |
|a Glucose
|2 NLM
|
650 |
|
7 |
|a IY9XDZ35W2
|2 NLM
|
700 |
1 |
|
|a Xu, Xuehui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Kewei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Yuqiu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Yangyuchen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Si, Qingrui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pan, Zi'an
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Jia, Fan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cui, Xinyue
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Xuan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Deng, Xiongwei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhao, Yi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shu, Dan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Jiang, Qiao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ding, Baoquan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wu, Yan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, Ran
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 35(2023), 29 vom: 21. Juli, Seite e2208820
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:35
|g year:2023
|g number:29
|g day:21
|g month:07
|g pages:e2208820
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202208820
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 35
|j 2023
|e 29
|b 21
|c 07
|h e2208820
|